Abstract Oligometastatic disease (OMD) in neuroendocrine tumors (NET) has hardly been investigated so far and it is unclear how OMD should influence treatment decisions. The primary objective of this retrospective analysis was to evaluate characteristics and prognosis of the OMD state in patients with NET G1/G2 of gastroenteropancreatic origin. The overall study cohort comprised 190 patients. OMD occurred in 29% of patients (n = 55), 58% of those (n = 32) had synchronous oligometastases.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Julia
Contact Julia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack